Chardan Capital Initiates Ophthotech At Buy

Analysts at Chardan Capital initiated coverage on

with a Buy rating. The target price for Ophthotech is set to $80. Ophthotech shares have gained 47.77% over the past 52 weeks, while the S&P 500 index has surged 14.85% in the same period. Ophthotech shares rose 1.29% to $54.00 in pre-market trading.